$255.480
-2.631 (-1.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABBV Prediction & Forecast by Similar Chart Analysis
Alphio's ABBV stock price prediction model matches the current AbbVie Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $256.55 (+0.42%). The 1-week path is $256.94 (+0.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy AbbVie Inc. Stock?
AbbVie Inc is a good buy right now due to its recent positive developments and strong financial indicators. The current price is $255.48, and the company has a forward P/E ratio of 18.69, indicating a reasonable valuation compared to its earnings potential. Additionally, AbbVie has raised its dividends for 54 consecutive years, with a recent payout of $1.73 per share, yielding 2.6%, which is attractive for long-term investors. However, the RSI is currently at 38.91, suggesting that the stock is approaching oversold territory, which could present a buying opportunity.
ABBV stock price ended at $255.48 on Friday, after losing -1.03%
AbbVie Inc. (ABBV) last closed at $255.48, losing -1.03%. These facts feed the 1-day and 1-week ABBV price prediction above.
Analyst Consensus
AbbVie Inc. (ABBV): 10 buy, 10 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
AbbVie Inc. (ABBV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABBV, ranked by similarity.
Seasonality analysis for ABBV
Historically the probability of a positive August return for ABBV is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABBV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $158.08 | $194.85 | $201.13 | -23.73% |
| Sep 2026 | $209.56 | $225.00 | $225.80 | -11.93% |
| Oct 2026 | $215.28 | $225.00 | $232.75 | -11.93% |
| Nov 2026 | $185.36 | $214.85 | $243.33 | -15.91% |
| Dec 2026 | $199.82 | $200.19 | $230.51 | -21.64% |
In 2026, AbbVie Inc. (ABBV) is projected to range from $158.08 to $243.33.
AbbVie Inc. 2026 monthly forecast
In Aug 2026, AbbVie Inc. is projected to average $194.85, with a low of $158.08 and high of $201.13.
In Sep 2026, AbbVie Inc. is projected to average $225.00, with a low of $209.56 and high of $225.80.
In Oct 2026, AbbVie Inc. is projected to average $225.00, with a low of $215.28 and high of $232.75.
In Nov 2026, AbbVie Inc. is projected to average $214.85, with a low of $185.36 and high of $243.33.
In Dec 2026, AbbVie Inc. is projected to average $200.19, with a low of $199.82 and high of $230.51.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.